<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2019-8-4-6-12</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-625</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИСТОРИЧЕСКИЕ АСПЕКТЫ. Организация здравоохранения и общественное здоровье</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HISTORICAL INSIGHTS. Public health</subject></subj-group></article-categories><title-group><article-title>Необходимо ли всем пациентам выполнять коронароангиографию для дифференциальной диагностики инфаркта миокарда 1-го и 2-го типа?</article-title><trans-title-group xml:lang="en"><trans-title>Should all patients undergo coronary angiography for diagnosing type 1 and 2 myocardial infarction?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородская</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodskaya</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самородская Ирина Владимировна - доктор медицинских наук, профессор, руководитель лаборатории демографических аспектов здоровья населения.</p><p>101990, Москва, Петроверигский пер., 10, стр. 3, тел. +7 (985) 224-60-50</p></bio><bio xml:lang="en"><p>Samorodskaya Irina V. - PhD, Professor, Head of the  Laboratory for Demographic Aspects of Population Health.</p><p> </p><p>101990, Moscow, 10, Petroverigsky LN, phone: +7 (985) 224-60-50</p></bio><email xlink:type="simple">samor2000@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федерального государственного бюджетного учреждения «Национальный медицинский исследовательский центр профилактической медицины» Министерства здравоохранения Российской<country>Россия</country></aff><aff xml:lang="en">Federal State Institution “National Medical Research Center for Preventive Medicine” of the Ministry of Healthcare of the Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2019</year></pub-date><volume>8</volume><issue>4</issue><fpage>6</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Самородская И.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Самородская И.В.</copyright-holder><copyright-holder xml:lang="en">Samorodskaya I.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/625">https://www.nii-kpssz.com/jour/article/view/625</self-uri><abstract><p>В дискуссионной статье рассмотрен вопрос о целесообразности проведения коронароангиографии (КАГ) всем пациентам для дифференциальной диагностики инфаркта миокарда 1-го и 2-го типа. С точки зрения оказания пациенту помощи - решение должно приниматься индивидуально с учетом соотношения пользы/риска. В основе обоснованного решения должен лежать принцип улучшения состояния пациента, облегчение симптомов заболевания, снижения риска смерти. В настоящее время недостаточно данных Резюме               для точного определения каким именно пациентам проведение КАГ определенно необходимо в качестве этапа решения вопроса о тактике ведения, поэтому требуется проведение дальнейших исследований. До получения надежных доказательств необходима согласованная позиция специалистов по обоснованию необходимости/целесообразности проведения КАГ в особых клинических ситуациях. Инвазивные исследования не должны выполняться ради уточнения диагноза с целью статистического учета и для исключения расхождения клинического и патологоанатомического диагноза.</p></abstract><trans-abstract xml:lang="en"><p>The article reports the feasibility of performing coronary angiography to all patients to diagnose type 1 and 2 MI. From the perspective of patient care, the decision should be individual and must be driven by the benefits and risks. The following underlying principles should be taken into account: improvement of a patient’s condition, alleviation of pain, and mortality risk-minimization. However, additional researches are required to obtain new evidences on selecting the target patient group who should be referred to CAG for future decision making, therefore further research is required. A consensual opinion of specialists justifying the need and rational for CAG in specific clinical cases situations is necessary before obtaining reliable evidences. Invasive interventions should not be performed to verify diagnosis for statistical purposes or exclusion of the discrepancies between clinical and pathological anatomical diagnosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>инфаркт миокарда</kwd><kwd>коронароангиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>myocardial infarction</kwd><kwd>coronary angiography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Четвертое универсальное определение инфаркта миокарда (2018). Российский кардиологический журнал. 2019;(3):107-138. doi:10.15829/1560-4071-2019-3-107-138</mixed-citation><mixed-citation xml:lang="en">Fourth universal definition of myocardial infarction (2018). Russian Journal of Cardiology. 2019;(3):107-138. doi:10.15829/1560-4071-2019-3-107-138). (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/ World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction. Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004.</mixed-citation><mixed-citation xml:lang="en">Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/ World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction. Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2018 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2018 Aug 25. doi: 10.1093/eurheartj/ehy394</mixed-citation><mixed-citation xml:lang="en">Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2018 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2018 Aug 25. doi: 10.1093/eurheartj/ehy394</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Writing Group, Manesh R. Patel, John H. Calhoon, Gregory J. Dehmer, James Aaron Grantham, Thomas M. Maddox, David J. Maron and Peter K. Smith ACC/AATS/AHA/ASE/ASNC/ SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons Coronary Revascularization. J Nucl Cardiol. 2017 Apr;24(2):439-463. doi: 10.1007/s12350-017-0780-8.</mixed-citation><mixed-citation xml:lang="en">Writing Group, Manesh R. Patel, John H. Calhoon, Gregory J. Dehmer, James Aaron Grantham, Thomas M. Maddox, David J. Maron and Peter K. Smith ACC/AATS/AHA/ASE/ASNC/ SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons Coronary Revascularization. J Nucl Cardiol. 2017 Apr;24(2):439-463. doi: 10.1007/s12350-017-0780-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Miller TD.Comparison of the AHA/ACC vs ESC guidelines for management of patients with non-ST-elevation acute coronary syndromes: Are the differences clinically different? J Nucl Cardiol. 2018 Jun;25(3):777-779. doi: 10.1007/s12350-018-1219-6. Epub 2018 Feb 7.</mixed-citation><mixed-citation xml:lang="en">Miller TD.Comparison of the AHA/ACC vs ESC guidelines for management of patients with non-ST-elevation acute coronary syndromes: Are the differences clinically different? J Nucl Cardiol. 2018 Jun;25(3):777-779. doi: 10.1007/s12350-018-1219-6. Epub 2018 Feb 7.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tideman PA, Woodruffe S, Kerr A, Branagan M, Aylward PE; NHFA/CSANZ ACS Guideline 2016 Executive Working Group:. National Heart Foundation of Australia &amp; Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart Lung Circ. 2016 Sep;25(9):895-951. doi: 10.1016/j.hlc.2016.06.789.</mixed-citation><mixed-citation xml:lang="en">Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tideman PA, Woodruffe S, Kerr A, Branagan M, Aylward PE; NHFA/CSANZ ACS Guideline 2016 Executive Working Group:. National Heart Foundation of Australia &amp; Cardiac Society of</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Silvain J, Nguyen LS, Spagnoli V, Kerneis M, Guedeney P, Vignolles N, Cosker K, Barthelemy O, Le Feuvre C, Helft G, Collet JP, Montalescot Gl. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2018;104(9):767-72. doi: 10.1136/heartjnl-2017-311975.</mixed-citation><mixed-citation xml:lang="en">Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart Lung Circ. 2016 Sep;25(9):895-951. doi: 10.1016/j.hlc.2016.06.789.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AATS/ PCNA/SCAI/ST S focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014 Nov 4;130(19): 1749-67. doi: 10.1161/CIR.0000000000000095</mixed-citation><mixed-citation xml:lang="en">Silvain J, Nguyen LS, Spagnoli V, Kerneis M, Guedeney P, Vignolles N, Cosker K, Barthelemy O, Le Feuvre C, Helft G, Collet JP, Montalescot Gl. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2018;104(9):767-72. doi: 10.1136/heartjnl-2017-311975.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem. 2017;63:101-7. doi: 10.1373/clinchem.2016.255521.</mixed-citation><mixed-citation xml:lang="en">Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AAT S/PCNA/ SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014 Nov 4;130(19): 1749-67. doi: 10.1161/CIR.0000000000000095</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">APACE Investigators.Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction. Am Coll Cardiol 2017;70:1558-68. doi: 10.1016/j.jacc.2017.07.774.</mixed-citation><mixed-citation xml:lang="en">Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem. 2017;63:101-7. doi: 10.1373/clinchem.2016.255521.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Etaher A, Gibbs OJ, Saad YM, Frost S, Nguyen TL, Ferguson I, Juergens CP, Chew D, French JK. Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing highinvasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department. Eur Heart J Qual Care Clin Outcomes. 2019 May 20. pii: qcz019. doi: 10.1093/ehjqcco/qcz019.</mixed-citation><mixed-citation xml:lang="en">APACE Investigators.Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction. Am Coll Cardiol 2017;70:1558-68. doi: 10.1016/j.jacc.2017.07.774.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ten Haaf Me, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y. Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands. Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.</mixed-citation><mixed-citation xml:lang="en">Etaher A, Gibbs OJ, Saad YM, Frost S, Nguyen TL, Ferguson I, Juergens CP, Chew D, French JK. Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department. Eur Heart J Qual Care Clin Outcomes. 2019 May 20. pii: qcz019. doi: 10.1093/ehjqcco/qcz019.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gudnadottir GS, James SK, Andersen K, Lagerqvist B, Thrainsdottir IS, Ravn-Fischer A, Varenhorst C, Gudnason T.Outcomes after STEMI in old multimorbid patients with complex health needs and the effect of invasive management. Am Heart J 2019;211:11-21. doi: 10.1016/j.ahj.2019.01.008.</mixed-citation><mixed-citation xml:lang="en">Ten Haaf Me, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y. Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands. Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe aS, Holmes DR Jr, Barsness GW Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.</mixed-citation><mixed-citation xml:lang="en">Gudnadottir GS, James SK, Andersen K, Lagerqvist B, Thrainsdottir IS, Ravn-Fischer A, Varenhorst C, Gudnason T.Outcomes after STEMI in old multimorbid patients with complex health needs and the effect of invasive management. Am Heart J 2019;211:11-21. doi: 10.1016/j.ahj.2019.01.008.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Damluji AA, Bandeen-Roche K, Berkower C, Boyd CM, Al-Damluji MS, Cohen MG6, Forman DE, Chaudhary R, Gerstenblith G, Walston JD, Resar JR, Moscucci M9.Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 23;73(15):1890-1900. DOI: 10.1016/j.jacc.2019.01.055</mixed-citation><mixed-citation xml:lang="en">Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe aS, Holmes DR Jr, Barsness GW Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sandoval Y, Jaffe AS. . Type 2 Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 Apr 16;73(14):1846-1860. doi: 10.1016/j.jacc.2019.02.018</mixed-citation><mixed-citation xml:lang="en">Damluji AA, Bandeen-Roche K, Berkower C, Boyd CM, Al-Damluji MS, Cohen MG6, Forman DE, Chaudhary R, Gerstenblith G, Walston JD, Resar JR, Moscucci M9.Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 23;73(15):1890-1900. DOI: 10.1016/j.jacc.2019.01.055</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, White H, Chuang AM, Tiver K, Quinn S, Kaambwa B, Horsfall M, Morton E, Chew DP. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design. Am Heart J. 2019 Feb;208:11-20. doi: 10.1016/j.ahj.2018.09.016.</mixed-citation><mixed-citation xml:lang="en">Sandoval Y, Jaffe AS. . Type 2 Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 Apr 16;73(14):1846-1860. doi: 10.1016/j.jacc.2019.02.018</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lattuca B,, Kerneis M, Zeitouni M, Cayla G, Guedeney P, Collet JP, Montalescot G, Silvain J.Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach. Drugs Aging. 2019 Jun;36(6):531-539. doi: 10.1007/ s40266-019-00663-y.</mixed-citation><mixed-citation xml:lang="en">Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, White H, Chuang AM, Tiver K, Quinn S, Kaambwa B, Horsfall M, Morton E, Chew DP. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design. Am Heart J. 2019 Feb;208:11-20. doi: 10.1016/j.ahj.2018.09.016.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shavadia JS, Chen AY, Fanaroff AC, de Lemos JA, Kontos MC, Wang TY Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion. JACC Cardiovasc Interv. 2019 Apr 22;12(8)709-717. doi: 10.1016/j.jacc.2019.01.055</mixed-citation><mixed-citation xml:lang="en">Lattuca B,, Kerneis M, Zeitouni M, Cayla G, Guedeney P, Collet JP, Montalescot G, Silvain J.Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach. Drugs Aging. 2019 Jun;36(6):531-539. doi: 10.1007/s40266-019-00663-y.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Courtwright A. “Who Is ‘Too Sick to benefit’? The Hastings Center report. 2012; 4: 41-47. doi: 10.1002/hast.51.</mixed-citation><mixed-citation xml:lang="en">Shavadia JS, Chen AY, Fanaroff AC, de Lemos JA, Kontos MC, Wang TY. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion. JACC Cardiovasc Interv. 2019 Apr 22;12(8)709-717. doi: 10.1016/j.jacc.2019.01.055</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Courtwright A. “Who Is ‘Too Sick to benefit’? The Hastings Center report. 2012; 4: 41-47. doi: 10.1002/hast.51.</mixed-citation><mixed-citation xml:lang="en">Courtwright A. “Who Is ‘Too Sick to benefit’? The Hastings Center report. 2012; 4: 41-47. doi: 10.1002/hast.51.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
